20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T30562 | BP | ||
BP is a rare class enhancer of proteasomal activation in the absence of a heat shock response. | |||
T9100 | BP 897 | 2-Naphthalenecarboxamide, N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]- | Dopamine Receptor |
BP 897 (2-Naphthalenecarboxamide, N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-) is a potent and selective dopamine D3 receptor agonist, and a weak dopamine D2 receptor antagonist, with Kis of 0.92 nM and 61 nM for D3 ... | |||
T14767 | BP 897 hydrochloride | Dopamine Receptor | |
BP 897 is a potent and selective agonist of dopamine D3 receptor and it is a weak dopamine D2 receptor antagonist, with Kis of 0.92 nM and 61 nM for D3 and D2 receptors. Which shows low affinities at D1 and D4 receptors ... | |||
T3708 | BP-1-102 | STAT | |
BP-1-102 is an orally active, effective and specific STAT3 inhibitor. BP-1-102 binds Stat3 (Kd: 504 nM), then blocks Stat3-phosphotyrosine (pTyr) peptide interactions and Stat3 activation (4-6.8 μM), and selectively inhi... | |||
T26890 | BP14979 | BP 14979,BP1,4979,BP-14979,BP 1,4979,BP-1,4979 | |
BP14979 is D3R-selective partial agonist. | |||
T70367 | SNU-BP | ||
SNU-BP is an agonist of PPAR-gamma, inhibiting lipopolysaccharide (LPS)-induced NO production and pro-inflammatory cytokines. SNU-BP potentiates interleukin-4-induced arginase-1 expression, and promotes microglial polari... | |||
T16071 | MGB-BP-3 | DNA/RNA Synthesis , Antibiotic | |
MGB-BP-3 is a synthetic antibiotic with bactericidal activity that inhibits bacterial DNA replication and can be used to study recurrent C. difficile infections. | |||
T70167 | BP-5-087 | ||
BP-5-087 is a STAT3 inhibitor, combining with BCR-ABL1 inhibition to overcome kinase-independent resistance in chronic myeloid leukemia. | |||
T70950 | BP-1-108 | ||
BP-1-108 is a potent and selective STAT5 inhibitor. | |||
T35364 | 2-Bromohexadecanoic acid | 2-BP,2-bromopalmitate,2-Bromohexadecanoic acid | Others |
2-Bromohexadecanoic acid (2-BP) is a non-metabolizable palmitate analogue, which can be used as palmitoylation inhibitor. 2-BP directly and irreversibly inhibits the palmitoyltransferase activity of all DHHC (Asp-His-His... | |||
T5882 | 3-Bromopyruvic acid | Hexokinase II Inhibitor II, 3-BP,Bromopyruvic acid | Apoptosis , Hexokinase , Autophagy |
3-Bromopyruvic acid (Hexokinase II Inhibitor II, 3-BP) is a hexokinase II inhibitor with Ki of 2.4 mM for glycolysis/hexokinase inhibition. It is inhibitor of tumour cell energy metabolism and chemopotentiator of platinu... | |||
T27306 | Fasidotril | BP 1137,BP1137,BP-1.137,BP1.137,BP-1137,BP 1.137 | |
Fasidotril is a NEP/ACE inhibitor. Fasidotril was an effective oral antihypertensive agent during chronic treatment in high-renin renovascular rats, normal-renin SHR, and low-renin DOCA-salt hypertensive rats and in pati... | |||
T13184 | Topilutamide | Fluridil,BP766 | Others |
Topilutamide (Fluridil) is a topical nonsteroidal antiandrogen. | |||
T25171 | BP13944 | BP 13944,BP-13944 | |
BP13944 is used as a potential dengue virus NS2B/NS3 protease inhibitor. | |||
T23698 | Aladotril | BP1137,BP 1137,BP-1137 | |
Aladotril is an inhibitor of neutral endopeptidase. Its prodrug is aladotrilat. | |||
T5514 | Epibrassinolide | 24-Epibrassinolide,B1105,BP55 | Apoptosis |
Epibrassinolide (BP55) (EBR) is a biologically active compound of the brassinosteroids, is a natural brassinosteroid (BR) derivative, is a plant regulator with a similar structure to mammalian steroids. | |||
T32183 | Iosimenol | MP-3047-04,ICJ 3393,ICJ-3393,BP-13 | |
Iosimenol is an amidobenzoic acid and a contrast agent. | |||
T20231 | Cellufluor | Phorwite AR,Paper White BP,Kayaphor FB,Tinopal 5BMS | |
Cellufluor is a fluorochrome. It has an affinity for chitin and cellulose. | |||
T31598 | Ecadotril | S.049,BAY-y 7432,BAY y 7432,BP 1.02,S049 | |
Ecadotril is a neutral endopeptidase (NEP) inhibitor, which plays an anti hypertensive role. | |||
T70446 | Abivertinib HCl | ||
Abivertinib, also known as AC0010 and Avitinib, is a third-generation EGFR tyrosine kinase inhibitor and BTK Inhibitor that demonstrated clinical efficacy and manageable adverse events (AEs). Abivertinib inhibits cell p... |